财报披露
Evogene(EVGN)06-07 04:05
$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001950 Act: 34 Size: 9 KB 网页链接
简介:Evogene Ltd.是一家从事研究和开发植物改良领域的生物技术公司。该公司于2000年作为Compugen公司(Compugen)的一个部分,并与2002成为一家独立的公司。这家公司专注于技术的发展来确定基因序列(即负责生产蛋白质的DNA序列---基因)和其他植物DNA序列,他有可能提高植物的性状。(靶植物和目标性状)。这些改进是通过吧靶基因通过基因改造引入到基因中去,或者通过先进的繁殖培养技术引入基因来相应的改变目标性状。此外,该公司涉及可能被用在未来的生产生物柴油工业的非食用的作物的提高和繁殖。
今开:0.59 | 昨收:0.6207 |
最高:0.59 | 最低:0.51 |
涨停价: | 跌停价: |
总市值:26854524 |
Evogene(EVGN)06-07 04:05
$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001950 Act: 34 Size: 9 KB 网页链接
Evogene(EVGN)06-21 04:15
$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-002015 Act: 34 Size: 8 KB 网页链接
Evogene(EVGN)06-18 04:15
$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001995 Act: 34 Size: 10 KB 网页链接
Evogene(EVGN)06-25 19:05
$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-002068 Act: 34 Size: 33 KB 网页链接
Evogene(EVGN)07-23 19:05
$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-002267 Act: 34 Size: 369 KB 网页链接
Evogene(EVGN)05-29 19:35
$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001873 Act: 34 Size: 8 MB 网页链接
Evogene(EVGN)05-23 19:05
$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001817 Act: 34 Size: 6 MB 网页链接
Evogene(EVGN)05-01 04:05
$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001488 Act: 34 Size: 1 MB 网页链接
Evogene(EVGN)05-23 23:05
$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001819 Act: 34 Size: 1 MB 网页链接
Takeabreak2021-12-31 14:34
$Evogene(EVGN)$ Added @1.68 Last adding was 2.6查看全文
Takeabreak2021-09-01 08:40
$Evogene(EVGN)$ 准备续写$阿米瑞斯(AMRS)$ 的故事(走势)??
Pre launch of medical cannabis. 网页链接查看全文
Takeabreak2021-04-20 23:15
$Evogene(EVGN)$ 4/21 investor day. 先high起来, 现在就是4刀时的 $阿米瑞斯(AMRS)$
$Compugen医疗(CGEN)$查看全文
lily962021-04-06 00:35
Takeabreak2021-03-11 23:24
Takeabreak2021-03-11 12:33
$Affimed(AFMD)$ We will see $10 in a few weeks, maybe 15-20, who knows.
Quote:
AFM13 is also being evaluated in combination with cord-blood derived natural killer cells in CD30-positive lymphomas at MD Anderson Cancer Center (MDACC). Initial data from this investiga...查看全文
Takeabreak2021-03-09 11:59
$Evogene(EVGN)$ 没有跟跌,貌似能够稳住!下4再小加,等到跌停止了,也有一些仓位了,心里舒服了,再好好买(磨)。半(1,2)年后,向上就有一定仓位了! 参考AMRS,喜欢看准了通过左侧重仓,右侧不会做技不如人查看全文
Takeabreak2021-03-06 01:06
$工艺酿酒联盟(HOOK)$ 今天你太亮了,BIO持仓中最靓的仔。跌幅最大的是$Evogene(EVGN)$ 还有$Kala制药(KALA)$ MDNA.......查看全文
Takeabreak2021-03-05 22:53
$Evogene(EVGN)$ 继续 -10%+, 就想问你服不服?查看全文
本轮募集资金将主要用于:完成肿瘤免疫项目BMC128的一期临床研究,并推进到二期临床试验;完成并扩大针对炎症性肠病(IBD)的BMC333项目的GMP生产,并为BMC333的一期临床试验进行准备工作;以及推进其他研发计划。 以色... 网页链接
$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-002267 Act: 34 Size: 369 KB 网页链接
$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-002068 Act: 34 Size: 33 KB 网页链接
$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-002015 Act: 34 Size: 8 KB 网页链接
$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001995 Act: 34 Size: 10 KB 网页链接
$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001950 Act: 34 Size: 9 KB 网页链接
$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001873 Act: 34 Size: 8 MB 网页链接
$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001819 Act: 34 Size: 1 MB 网页链接
$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001817 Act: 34 Size: 6 MB 网页链接
$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001488 Act: 34 Size: 1 MB 网页链接
$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001182 Act: 34 Size: 46 KB 网页链接